Delayed targeting of cytokine-nonresponsive human bone marrow CD34+ cells with retrovirus-mediated gene transfer enhances transduction efficiency and long-term expression of transduced genes

Blood

Volumn 91, Issue 10, 1998, Pages 3693-3701

  Veena, Ponnazhagan ^a   Traycoff, Christie M ^a   Williams, David A ^a   McMahel, Jon ^a   Rice, Susan ^a   Cornetta, Ken ^a   Srour, Edward F ^a,b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; STEM CELL FACTOR; VIRUS VECTOR;

ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CELL SELECTION; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENE TARGETING; GENETIC TRANSDUCTION; GROWTH REGULATION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

EID: 0032525157     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.10.3693.3693_3693_3701     Document Type: Article

References (49)

1. Williams DA: Expression of introduced genetic sequences in hematopoietic cells following retroviral-mediated gene transfer. Hum Gene Ther 1:229, 1990
2. Apperley JF: Gene therapy: Current status and future directions. B J Haemat 75:148, 1990
3. Krauss JC: Hematopoietic stem cell gene replacement therapy. Biochim Biophys Acta 1114:193, 1992
4. Anderson WF: Human gene therapy. Science 256:808, 1992
5. Miller AD: Human gene therapy comes of age. Nature 357:455, 1992
6. Mulligan RC: The basic science of gene therapy. Science 260:926, 1993
7. Miller DG, Mohammed AA, Miller AD: Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol Cell Biol 10:4239, 1990
8. Hodgson GS, Bradley TR: Properties of haemopoietic stem cells surviving 5-fluorouracil treatment: Evidence for a pre-CFU-S cell? Nature 281:381, 1979
9. Lerner C, Harrison DE: 5-Fluorouracil spares hemopoietic stem cells responsible for long-term repopulation. Exp Hematol 18:114, 1990
10. + hemopoietic stem cells. J Exp Med 175:1443, 1992
11. Van Zant G, Scott-Micus K, Thompson BP, Fleischman RA, Perkins S: Stem cell quiescence/activation is reversible by serial transplantation and is independent of stromal cell genotype in mouse aggregation chimeras. Exp Hematol 20:470, 1992
12. Williams DA: Ex vivo expansion of hematopoietic stem and progenitor cells-Robbing Peter to pay Paul? Blood 81:3169, 1993 (editorial)
13. Srour EF, Brandt JE, Briddell RA, Grigsby S, Leemhuis T, Hoffman R: Long-term generation and expansion of human primitive hematopoietic progenitor cells in vitro. Blood 81:661, 1993
14. + cells into the myeloid lineage. Blood 80:1405, 1992
15. Sutherland HJ, Hogge DE, Eaves CJ: Growth factor regulation of the maintenance and differentiation of human long-term culture-initiating cells (LTC-IC). Leukemia 7:S122, 1993 (suppl)
16. Koller MR, Palsson MA, Manchel I, Palsson BO: Long-term culture-initiating cell expansion is dependent on frequent medium exchange combined with stromal and other accessory cell effects. Blood 86:1784, 1995
17. Nolta JA, Kohn DB: Comparison of the effects of growth factors on retroviral vector-mediated gene transfer and the proliferative status of human hematopoietic progenitor cells. Hum Gene Ther 1:257, 1990
18. Hughes PF, Thacker JD, Hogge D, Sutherland HJ, Thomas TE, Lansdorp PM, Eaves CJ, Humphries RK: Retroviral gene transfer to primitive normal and leukemic hematopoietic cells using clinically applicable procedures. J Clin Invest 89:1817, 1992
19. Dick JE, Kamel-Reid S, Murdoch B, Doedens M: Gene transfer into normal human hematopoietic cells using in vitro and in vivo assays. Blood 78:624, 1991
20. Larochelle A, Vormoor J, Hanenberg H, Wang JC, Bhatia M, Lapidot T, Moritz T, Murdoch B, Xiao XL, Kato I, Williams DA, Dick JE: Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: Implications for gene therapy. Nat Med 2:1329, 1996
21. Brenner MK, Rill DR, Moen RC, Krance RA, Mirro J Jr, Anderson WF, Ihle JN: Gene-marking to trace origin of relapse after autologous bone-marrow transplantation. Lancet 341:85, 1993
22. Brenner MK, Rill DR, Holladay MS, Heslop HE, Moen RC, Buschle M, Krance RA, Santana VM, Anderson WF: Gene marking to determine whether autologous marrow infusion restores long-term haematopoiesis in cancer patients. Lancet 342:1134, 1993
23. Traycoff CM, Kosak ST, Grigsby S, Srour EF: Evaluation of ex vivo expansion potential of cord blood and bone marrow hematopoietic progenitor cells using cell tracking and limiting dilution analysis. Blood 85:2059, 1995
24. Srour E, Bregni M, Traycoff C, Aguero B, Kosak S, Huffman R, Siena S, Gianni A: Long-term hematopoietic culture-initiating cells are more abundant in mobilized peripheral blood grafts than in bone marrow but have a more limited ex vivo expansion potential. Blood Cells Mol Dis 22:68, 1996
25. Traycoff CM, Cornetta K, Yoder MC, Davidson A, Srour EF: Ex vivo expansion of murine hematopoietic progenitor cells generates classes of expanded cells possessing varying levels of bone marrow repopulating potentials. Exp Hematol 24:299. 1996
26. Berardi AC, Wang A, Levine JD, Lopez P, Scadden DT: Functional isolation and characterization of human hematopoietic stem cells. Science 267:104, 1995
27. Traycoff CM, Abboud MR, Laver J, Brandt JE, Huffman R, Law P, Ishizawa L, Srour EF: Evaluation of the in vitro behavior of phenotypically defined populations of umbilical cord blood hematopoietic progenitor cells. Exp Hematol 22:215, 1994
28. + hematopoietic progenitor cells residing in G0. Blood 90:658, 1997
29. + cells. Exp Hematol 26:53, 1998
30. Moritz T, Patel V, Williams DA: Bone marrow extracellular matrix molecules improve gene transfer into human hematopoietic cells via retroviral vectors. J Clin Invest 93:1451, 1994
31. Bender MA, Palmer TD, Gelinas RE, Miller AD: Evidence that the packaging signal of Moloney murine leukemia virus extends into gag region. J Virol 61:1639, 1987
32. Cornetta K, Moen RC, Culver K, Morgan RA, McLachlin JR, Sturm S, Selegue JE, London WT, Blaese RM, Anderson WF: Amphotropic murine leukemia retrovirus is not an acute pathogen for primates. Hum Gene Ther 1:13, 1990
33. + cells isolated in subcompartments of the G0/G1 phase of the cell cycle. Blood 90:4384, 1997
34. Roe T, Reynolds TC, Yu G, Brown PO: Integration of murine leukemia virus DNA depends on mitosis. EMBO J 12:2099, 1993
35. Nolta JA, Smogorzewska EM, Kohn DB: Analysis of optimal conditions for retroviral-mediated transduction of primitive human hematopoietic cells. Blood 86:101, 1995
36. + cells present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow in CML. Blood 83:3068, 1994
37. Kohn DB, Weinberg KI, Nolta JA, Heiss LN, Lenarsky C, Crooks GM, Hanley ME, Annett G, Brooks JS, El-Khoureiy A, Lawrence K, Wells S, Moen RC, Bastian J, Williams-Herman DE, Elder M, Wara D, Bowen T, Hershfield MS, Mullen CA, Blaese RM, Parkman R: Engraftment of gene-modified umbilical cord blood cells in neonates with adenosine deaminase deficiency. Nat Med 1:1017, 1995
38. Dunbar CE, Cottler-Fox M, O'Shaughnessy JA, Doren S, Carter CS, Berenson R, Brown S, Moen RC, Greenblatt J, Stewart FM, Leitman SF, Wilson W, Cowan KH, Young NS, Nienhuis AW: Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantation. Blood 85:3048, 1995
39. Cornetta K, Srour EF, Moore A, Davidson A, Broun ER, Hromas R, Moen RC, Morgan RA, Rubin L, Anderson WF, Hoffman R, Tricot G: Retroviral gene transfer in autologous bone marrow transplantation for adult acute leukemia. Hum Gene Ther 7:1323, 1996
40. Verfaillie CM, Miller JS: A novel single-cell proliferation assay shows that long-term culture-initiating cell (LTC-IC) maintenance over time results from the extensive proliferation of a small fraction of LTC-IC. Blood 86:2137, 1995
41. Young JC, Varma A, DiGiusto D, Backer MP: Retention of quiescent hematopoietic cells with high proliferative potential during ex vivo stem cell culture. Blood 87:545, 1996
42. + cells for six hours without growth factors or on autologous stroma does not improve marking efficiency assessed in vivo. Blood 89:4040, 1997
43. Randall TD, Weissman IL: Phenotypic and functional changes induced at the clonal level in hematopoietic stem cells after 5-fluorouracil treatment. Blood 89:3596, 1997
44. Luskey BD, Rosenblatt M, Zsebo K, Williams DA: Stem cell factor, interleukin-3, and interleukin-6 promote retroviral-mediated gene transfer into murine hematopoietic stem cells. Blood 80:396, 1992
45. Brenner MK: Gene transfer into human hematopoietic progenitor cells: A review of current clinical protocols. J Hematother 2:7, 1993
46. Boezeman J, Raymakers R, Vierwinden G, Linssen P: Automatic analysis of growth onset, growth rate and colony size of individual bone marrow progenitors. Cytometry 28:305, 1997
47. Bhatia M, Bonnet D, Kapp U, Wang JCY, Murdoch B, Dick JE: Quantitative analysis reveals expansion of human hematopoietic repopulating cells after short-term ex vivo culture. J Exp Med 186:619, 1997
48. + progenitors to sustain long-term hematopoiesis in immune-deficient mice after ex vivo retroviral-mediated transduction. Blood 89:446, 1997
49. Dao MA, Yu XJ, Nolta JA: Clonal diversity of primitive human hematopoietic progenitors following retroviral marking and long-term engraftment in immune-deficient mice. Exp Hematol 25:1357, 1997